Drugs that contain Amlodipine Besylate
1. Drug name - AMLODIPINE BESYLATE
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6828339 | SYNTHON PHARMS | Amlodipine salt forms and processes for preparing them |
Nov, 2022
(a month from now) | |
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 2.5MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL | Discontinued |
| EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL | Discontinued |
| EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL | Discontinued |
2. Drug name - NORLIQVA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11253474 | CMP DEV LLC | Pharmaceutical solution of amlodipine |
Feb, 2041
(18 years from now) | |
Treatment: Norliqva is indicated for the treatment of hypertension, to lower blood pressure in adults and children 6 years of age and older; norliqva is indicated for the symptomatic treatment of chronic stable angina; norliqva is indicated for the treatment of confirmed or suspected vasospastic angina
Dosage: SOLUTION;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 1MG BASE/ML | SOLUTION;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.